Physician profile
Jordan Chen
NPI 1154852796
$7,965.47
in general payments reported to CMS, 2019-2025
19 companies · $357 in 2025
The $357 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $2,779 · 2023: $4,598 · 2024: $232 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,969 · Food and Beverage: $2,217.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,968.89 |
| Food and Beverage | $2,217.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,004.67 | 2022-2023 | Proclaim |
| Nevro Corp. | $1,795.32 | 2022-2023 | Senza |
| Medtronic, INC. | $1,474.44 | 2022-2024 | Synchromedii, Intellis Adaptivestim |
| Boston Scientific Corporation | $703.95 | 2022-2025 | Superion Indirect Decompression System, Wavewriter Alpha Prime 16, Spectra Wavewriter |
| Stratus Medical, LLC | $156.90 | 2023-2025 | Nimbus |
| Merck Sharp & Dohme LLC | $156.64 | 2024-2025 | Bridion |
| Abbvie INC. | $145.44 | 2023-2025 | Botox |
| Stimwave Technologies Incorporated | $113.15 | 2022 | |
| Grt US Holding, INC. | $99.70 | 2022 | |
| Solventum Corporation | $55.34 | 2025 | Bair Hugger |
| Curonix LLC | $46.57 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Edwards Lifesciences Corporation | $44.90 | 2024 | Hemosphere |
| Averitas Pharma INC. | $42.61 | 2023 | Qutenza |
| Spr Therapeutics, INC | $30.28 | 2022-2023 | Sprint Pns System |
| Fisher & Paykel Healthcare INC | $28.21 | 2025 | Fisher & Paykel Healthcare |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $22.69 | 2022 | |
| Collegium Pharmaceutical, INC. | $19.36 | 2023 | Xtampza |
| Tersera Therapeutics LLC | $16.15 | 2023 | Prialt |
| Saluda Medical Americas, INC. | $9.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.